Chitosan Based Nanoparticles in Drug Delivery
DOI:
https://doi.org/10.37285/ijpsn.2009.2.2.4Abstract
Nanoparticles have gained considerable attention in recent years as one of the most promising drug delivery systems owing to their unique potentials via combining the different characteristics of hydrophilicity and hydrophobicity with a nanoparticle (e.g., very small size). Several polymeric nanoparticulate systems have been prepared and characterized in recent years, based on both natural and synthetic polymers, each with its own advantages and drawbacks. Among the natural polymers, chitosan has been studied extensively for preparation of nanoparticles. Chitosan nanoparticles have been reported with different characteristics with respect to drug delivery. This review presents various types of chitosan based nanoparticles in drug delivery.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
References
A. Bernkop-Schnürch, G. Walker, Multifunctional matrices for oral peptide delivery. Crit. Rev. Ther. Drug Carr. Syst. 18: 459-501(2001).
A. Berthold, K. Cremer, J. Kreuter, Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Release. 39: 17-25(1996).
A. Maitra, Determination of size parameters of water–Aerosol OT–oil reverse micelles from their nuclear magnetic resonance data. J. Phys. Chem. 88: 5122-5125(1984).
A. Ragusa, I. García, S. Penadés, Nanoparticles as nonviral gene delivery vectors, IEEE Trans. Nanobioscience. 6: 319-330(2007).
C.M. Lehr, J.A. Bowstra, E.H. Schacht, H.E. Junginger, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78: 43-48(1992).
G. Borchard, H.L. Lueben, G.A. De Boer, J. Coos Verhoef, C.M. Lehr, H.E. Junginger, The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III: Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro. J. Control. Rel. 39: 131-138(1996).
H. Tokumitsu, H. Ichikawa, Y. Fukumori, Chitosan–gadopentetic acid complex nanoparticles for gadolinium neutron capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm. Res. 16: 1830-1835(1999).
H.J.Watzke, C.Dieschbourg,Novel silica-biopolymer nanocomposites: the silica sol–gel process in biopolymer organogels. Adv. Colloids Interface Sci. 50: 1-14(1994).
I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54: 631-651 (2002).
I.F. Uchegbu, A.G. Schätzlein, L. Tetley, A.I. Gray, J. Sludden, S. Siddique, E. Mosha, Polymeric chitosan-based vesicles for drug delivery. J. Pharm. Pharmacol. 50: 453-458(1998).
I.M. Van der Lubben, J.C. Verhoef, G. Borchard, H.E. Junginger, Chitosan for mucosal vaccination. Adv. Drug Deliv. Rev. 52: 139-144(2001).
J. Knapczyk, L. Krowczynski, J. Krzck, M. Brzeski, E. Nirnberg, D. Schenk,H. Struszcyk, Requirements of chitosan for pharmaceutical and biomedical applications, in: G. Skak-Braek, T. Anthonsen, P. Sandford (Eds.), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier, London. 1989, pp. 657-663.
J. Panyam, V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55: 329–347(2003).
J.D. Kingsley, H. Dou, J. Morehead, B. Rabinow, H.E. Gendelman, C.J. Destache, Nanotechnology: a focus on nanoparticles as a drug delivery system. J. Neuroimmune Pharmacol. 1: 340-350(2006).
K. Cho, X. Wang, S. Nie, Z.G. Chen, D.M. Shin, Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 14: 1310-1316(2008).
K. Ray, H.Q. Mao, K.Y. Lin, S.K. Huang, K.W. Leong, Oral immunization with DNA chitosan nanoparticles, Proc. Int. Symp. Control. Release Mater. 26: 348-349(1999).
K.A. Janes, P. Calvo, M.J. Alonso, Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Del. Rev. 47: 83-97(2001).
K.H.Min,K.Park, Y.S. Kim, S.M. Bae, S. Lee,H.G. Jo, R.W. Park, I.S.Kim,S.Y. Jeong,K.Kim, I.C. Kwon, Hydrophobically Modified Glycol Chitosan Nanoparticles-Encapsulated Camptothec in Enhance the Drug Stability and Tumor Targeting in Cancer Therapy, J. Control release 127: 208-218(2008).
K.Y. Lee, I.C. Kwon, Y.-H. Kim, W.H. Jo, S.Y. Jeong, Preparation of chitosan selfaggregates as a gene delivery system. J. Control. Release. 51: 213-220(1998).
K.Y. Lee, I.C. Kwon, Y.-H. Kim, W.H. Jo, S.Y. Jeong, Structural investigation of chitosan self-aggregates prepared for gene delivery, Proc. Int. Symp. Control. Rel. Bioact. Mater. 25: 340-341(1998).
M. George, T.E. Abraham, Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan. J. Control. Release. 114: 1-14(2006).
M. Nahar, T. Dutta, S. Murugesan, A. Asthana, D. Mishra, V. Rajkumar, M. Tare, S. Saraf, N.K. Jain, Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit. Rev. Ther. Drug Carr. Syst. 23: 259-318(2006).
M. Patel, T. Shah, A. Amin, Therapeutic opportunities in colon-specific drug delivery systems. Crit. Rev. Ther. Drug Carr. Syst. 24: 147-202(2007).
M. Prabaharan, J.F. Mano, Stimuli-responsive hydrogels based on polysaccharides incorporated with thermo-responsive polymers as novel biomaterials. Macromol. Biosci. 6: 991-1008(2006).
N.G.M. Schipper, K.M. Varum, P. Artursson, Chitosan as absorption enhancers for poorly absorbable drugs 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelia (Caco-29 cells). Pharm. Res. 13: 1686-1692(1996).
N.G.M. Schipper, K.M. Varum, P. Stenberg, G. Ockind, H. Lennernäis, P. Artursson, Chitosan as absorption enhancers for poorly absorbable drugs 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8: 335-343(1999).
N.G.M. Schipper, S. Olsson, A.J. Hoostraate, A.G. De Boer, K.M. Varum, P. Artursson, Chitosan as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 14: 923-929(1997).
P. Artursson, T. Lindmark, S.S. Davis, L. Illum, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res.11: 1358-1361(1994).
P. Calvo, C. Remunan-Lopez, J.L. Vila-Jata, M.J. Alonso, Novel hydrophilic chitosanpolyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63: 125-132(1997).
P.C. Bersch, B. Nies, A. Liebendorfer, Evaluation of the biological properties of different wound dressing materials. J. Mater. Sci. Med. 6: 231-240(1995).
P.L. Luisi, M. Giomini, M.P. Pileni, B.H. Robinson, Reverse micelles as hosts for proteins and small molecules. Biochim. Biophys. Acta. 947: 209-246(1988).
P.R. Lockman, R.J.Mumper, M.A. Khan, D.D. Allen, Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev. Ind. Pharm. 28: 1-13(2002).
Q. Gan, T.Wang, C. Cochrane, P. McCarron, Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf. B Biointerfaces. 44: 65-73(2005).
R. Fernandez-Urrusuno, P. Cavlo, C. Remunan-Lopez, J.L. Vila-Jato, M.J. Alonso, Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16: 1576-1581(1999).
R. Pandey, Z. Ahmad, S. Sharma, G.K. Khuller, Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. Int. J. Pharm. 301: 268-276(2005).
S. Hirano, H. Seino, I. Akiyama, I. Nonaka, Chitosan: a biocompatible material for oral and intravenous administration, in: C.G. Gebelein, R.L. Dunn (Eds.), Progress in Biomedical Polymers, Plenum Press, New York, 1990, pp. 283-289.
S. Hirano, H. Seino, Y. Akiyama, I. Nonaka, Biocompatibility of chitosan by oral and intravenous administration. Polym. Eng. Sci. 59: 897-901(1989).
S. Ichikawa, S. Iwamoto, J. Watanabe, Formation of biocompatible nanoparticles by self-assembly of enzymatic hydrolysates of chitosan and carboxymethyl cellulose. Biosci. Biotechnol. Biochem. 69: 1637-1642(2005).
S. Mitra, U. Gaur, P.C. Ghosh, A.N. Maitra, Tumor targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J. Control. Release. 74: 317-323(2001).
S. Sharma, J. Kulkarni, A.P. Pawar, Permeation enhancers in the transmucosal delivery of macromolecules. Pharmazie 61: 495-504(2006).
S. Shirashi, T. Imai, M. Otagiri, Controlled release of indomethacin by chitosan–polyelectrolyte complex: optimization and in vivo: in vitro evaluation. J. Control. Release. 25: 217-225(1993).
S. Yu, J. Hu, X. Pan, P. Yao, M. Jiang, Stable and pH-sensitive nanogels prepared by self-assembly of chitosan and ovalbumin. Langmuir 22: 2754-2759(2006).
S.K. Sahoo, V. Labhasetwar, Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8: 1112-1120(2003).
S.M. Moghimi, A.C. Hunter, J.C. Murray, Long-circulating and target specific nanoparticles: theory to practice. Pharmacol. Rev. 53: 283-318(2001).
S.V. Vinagradov, T.K. Bronich, A.V. Kabanov, Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv. Drug Deliv. Rev. 54 (1): 135-147 (2002).
T.G. Shutava, Y.M. Lvov, Nano-engineered microcapsules of tannic acid and chitosan for protein encapsulation. J. Nanosci. Nanotechnol. 6: 1655-1661(2006).
T.H. Dung, S.R. Lee, S.D. Han, S.J. Kim, Y.M. Ju, M.S. Kim, H. Yoo, Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment. J. Nanosci. Nanotechnol. 7: 3695-3699(2007).
V. Dodane, D. Vilivalam, Pharmaceutical applications of chitosan. Pharm. Sci. Technol. Today. 16: 246-253(1998).
W. Paul, C. Sharma, Chitosan, a drug carrier for the 21st century. S.T.P. Pharm. Sci. 10: 5-22(2000).
X.X. Tian, M.J. Groves, Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. J. Pharm. Pharmacol. 51: 151-157(1999).
X.Z. Shu, K.J. Zhu, A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int. J. Pharm. 201: 51-58(2000).
Y. Kato, H. Onishi, Y. Machida, Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol. 4: 303-309(2003).
Y. Kawashima, T. Handa, H. Takenaka, S.Y. Lin, Y. Ando, Novel method for the preparation of controlled-release theophylline granules coatedwith a polyelectrolyte complex of sodium polyphosphate-chitosan. J. Pharm. Sci. 74: 264-268(1985).
Y. Ohya, M. Shiratani, H. Kobayashi, T. Ouchi, Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem. 31: 629-642(1994).
Y. Ohya, R. Cai, H. Nishizawa, K. Hara, T. Ouchi, Preparation of PEG-grafted chitosan nano-particle for peptide drug carrier, Proc. Int. Symp. Control. Release Bioact. Mater. 26: 655-656(1999).
Y. Pan, Y. Li, H. Zhao, J. Zheng, H. Xu, G. Wei, J. Hao, F. Cui, Chitosan nanoparticles improve the intestinal absorption of insulin in vivo, Int. J. Pharm. 249 (2002) 139–147.
Y. Xu, Y. Du, Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm. 250: 215-226(2003).
Y.F. Fan, Y.N.Wang, Y.G. Fan, J.B. Ma, Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int. J. Pharm. 324: 158-167(2006).
Y.S. Leong, F. Candau, Inverse microemulsion polymerization. J. Phys. Chem. 86: 2269-2271(1982).
